First cancer. Now, Parkinson’s?
The idea that one disease is actually several, each driven by its own genetics and differing in everything from age of onset to response to drugs, made cancer the poster child for precision medicine. Now, a $4 million study announced on Monday aims to see whether a genetically informed precision-medicine approach might work for Parkinson’s, too.
Cancel my subscription. Your site is impossible to work with:
1. You never remember my password and constantly need it resubmitted
2. When I click “forgot your password” there is no response
3.STAT is not a convenient site to work with
John has parkinsons
Comments are closed.